go back

Washington, DC rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $1,513,561 · 10th–90th $489,779–$1,862,0870%20%40%10th90th$1,513,561Professionalmedian $489,779 · 10th–90th $489,779–$549,5410%50%90th$489,779$100.0K$200.0K$500.0K$1.0M$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $1,513,561.25 / $1,862,087.14
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $549,540.87
CareFirst
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$676,082.98 / $758,577.58 / $1,584,893.19
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $588,843.66
Kaiser Permanente
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$416,869.38 / $489,778.82 / $549,540.87
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $549,540.87
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$371,535.23 / $512,861.38 / $741,310.24